Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1167 | Thyroid cancer | ECE2018

TSH level and risk of malignancy in patients with thyroid nodules with Bethesda IV Cytopathology System

Moujir Carolina Fernandez-Trujillo , Perez Carlos Antonio Rodriguez , Arencibia Dunia Marrero , Plasencia Yaiza Lopez , Zaballo Julio Perez , Galvan Jose Cabrera , Mogollon Francisco Javier Novoa , Cortes Mauro Boronat

Introduction: Fine needle aspiration biopsy (FNAB) is the mainstay diagnostic procedure for evaluation of thyroid nodules, but it doesn’t permit to distinguish between benign and malignant follicular lesions (category IV in the Bethesda Cytopathology System). Some reports have suggested an association between increased serum levels of TSH and thyroid cancer. However, the specific relationship between TSH and malignancy has been scarcely studied in follicu...

ea0073ep78 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Influence of diabetes mellitus on mortality in patients hospitalized with COVID-19

Rodriguez Escobedo Raul , Fernando García Urruzola , Lanes Iglesias Soraya , Alonso Felgueroso Carlos , Martinez Tames Gema , Gutierrez Hurtado Alba , Gonzalez Vidal Tomas , Delgado Elias , Edelmiro Luis Menendez Torre

IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has generate a pandemic disease around the world. It has been documented that diabetes mellitus (DM) acts as a risk factor among people hospitalized with coronavirus disease (COVID-19). The objective of this study is to test if DM may unfavorably influence the outcome of COVID-19.MethodsData from Hospital Universitario Central ...

ea0098b3 | Basic Science | NANETS2023

Translational biomarkers in G2-3 NENs: Analysis from NET-001 and NET-002 trials

Nunez Jose E. , Bruce Jeffrey , Danesh Arnavaz , Chan David L. , Rodriguez-Freixinos Victor , Hallet Julie , Myrehaug Sten , Law Calvin , Pugh Trevor , Singh Simron

Background: The treatment of neuroendocrine neoplasms (NENs) of higher grade remains a dilemma. In these patients the role of immunotherapy is still unclear and predictive biomarkers are an unmet need. Herein, we present a revised translational analysis of the NET001 and NET002 (NCT03278405, NCT03278379) clinical trials.Methods: Patients with advanced WHO G2-3 NENs who had a gastroenteropancreatic (GEP) or a bronchial primary (excluding typical carcinoid...

ea0098c17 | Clinical – Chemo/SSA/Biologics | NANETS2023

Argentinian registry of gastric neuroendocrine tumors: A closer look at type 1

Oviedo Ana , Luca Romina , Bestani Claudia , Rodriguez Andres , Waisberg Federico , Ypa Carla , Catani Greta , Acosta Andrea , Maquieira Julian , Pombo Teresa , Kujaruk Mirta , Mendez Guillermo , O'Connor Juan

Background: Gastric neuroendocrine tumors (gNETs) are relatively uncommon. Represent up to 23% of all digestive neuroendocrine neoplasms. The majority are incidentally diagnosed from histology of ‘simple’ gastric polyps identified at endoscopy. There are 3 groups of gNETs: types 1, 2 and 3 with different pathogeneses, biological and clinical behaviors. It is worth mentioning that recent reports suggest a fourth type of gNETs1. Type I represents 75–80%...

ea0098c42 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Treatment with Lutetium in a real-world setting: How does it affect patient experience and their time-toxicity?

Romina Luca Maria , Cecilia Vazquez Eliana , Waisberg Federico , Catani Greta , Oviedo Ana , Musumeci Martina , Rodriguez Andres , Bortz Marcos , Esteso Federico , Chacon Matias , Manuel Oconnor Juan , Racioppi Silvina

Background: Lutetitum-177 (Lu-DOTATE) is an approved treatment regimen for patients with advanced neuroendocrine tumors (NETs). Improving patient experience is one of main goals of a cancer treatment plan. "Time-toxicity" describes the period that patients spend in doing administrative or medical procedures, including medical visits, scans, lab analyses, emergency room admissions, drug applications and hospitalizations. Modern therapies are usually approved after an im...

ea0099oc7.5 | Oral Communications 7: Endocrine-related Cancer | ECE2024

Characterization and targeting of serpins alteration in chronic liver disease and hepatocellular carcinoma

Herman-Sanchez Natalia , Serrano-Jimenez Maria , Amado Victor , Rodriguez-Peralvarez Manuel , Luque Raul M , Lopez-Canovas Juan L. , Gahete Manuel D.

Hepatocellular carcinoma (HCC) is an aggressive tumour frequently associated to an underlying chronic liver disease. In this sense, metabolic dysfunction-associated steatotic liver disease (MASLD) is considered as a growing cause of HCC development. Considering the need of novel therapeutic approaches, and the promising data about targeting the tumour microenvironment in cancer, we performed quantitative proteomics on HCC samples to characterize the components and regulators o...

ea0099p456 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Ghrelin system as a novel source of biomarkers and therapeutic tools in metabolic liver diseases

Garcia-Estrada Antonio , Herman-Sanchez Natalia , Ojeda Perez Betsaida , Cordoba-Chacon Jose , Sarmento-Cabral Andre , Rodriguez-Peralvarez Manuel , M. Luque Raul , Luis Lopez-Canovas Juan , D. Gahete Manuel

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the main hepatic manifestation of obesity. MASLD was recently defined as liver steatosis in the presence of at least one cardiometabolic risk factor and reduced or absent alcohol intake. MASLD prevalence is rapidly increasing, thus becoming the fastest growing aetiology of the most common primary liver cancer, hepatocellular carcinoma (HCC), and the leading cause of liver transplantation in HCC patients. Curre...

ea0099p591 | Late-Breaking | ECE2024

Safety of continous subcutaneous insulin infusion therapy in adults with type 1 diabetes during hospitalization

Torrecillas del Castillo Eduardo , Jimenez Varo Ignacio , Peinado Ruiz Mercedes , Rodriguez de Vera Pablo , Serrano Olmedo Isabel , Asuncion Martinez Brocca Maria

Aim: The use of continuous subcutaneous insulin infusion (CSII) systems in type 1 diabetic patients (DM1) is progressively increasing, leading to an increase in cases in which its maintenance during hospitalization is considered. The objective of the study is to analyze the safety of glycemic control with CSII therapy during hospitalization in DM1 adults.Material and Methods: Retrospective observational study on a cohort of DM1 people hospitalized the la...

ea0099ep1048 | Calcium and Bone | ECE2024

A bibliometric approach to scientific production on familialhypophosphatemic rickets in scopus (2000-2022)

Hernandez Garcia Frank , Gil Pena Helena , Rodriguez Suarez Julian , Lopez Garcia Jose , Oro Carbajosa Patricia , Fuente Perez Rocio , Corrales Reyes Ibrain

Background: Hypophosphatemic rickets are disabling conditions that negatively impact physical functioning, activities of daily living, mental health, social life, and leisure activities. The most common cause of Hypophosphatemic rickets is genetic factors, such as X-linked hypophosphatemia. The evaluation of the scientific application of familial hypophosphatemic rickets aids in understanding the research landscape, identifying opportunities for improvement, and promoting sign...

ea0099ep1308 | Late Breaking | ECE2024

Thyroid replacement therapy with liquid levothyroxine as an alternative for patients with gastrointestinal absorption problems

Torrecillas del Castillo Eduardo , Peinado Ruiz Mercedes , Rodriguez de Vera Pablo , Torres Cuadro Alberto , Garcia Socorro Clara , Asuncion Martinez Brocca Maria , Martin Hernandez Tomas

Aim: Illustrating a case series of two patients with levothyroxine malabsorption and suboptimal control of the thyroid profile who experienced a significant improvement after switching to liquid levothyroxine.Material and Methods: Case saries of two patients who were attended in monographic thyroid pathology consultations at Virgen Macarena University Hospital.Results: Case 1: a 46-year-old female patient who had multinodular goitr...